This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Switching antidepressant (vortioxetine to monoamine oxidase inhibitors (MAOIs)) in adults

Authoring team

Vortioxetine to monoamine oxidase inhibitors (MAOIs)

  • switching to an MAOI is always a complex switch and you should follow specialist advice.

Taper, washout and switch with specialist advice

  • gradually reduce the dose of vortioxetine and stop; wait 14 to 21 days before starting the MAOI

  • the specialist will advise the duration of the washout period on a case-by-case basis taking into consideration the MAOI being started

  • cross-tapering is not recommended due to the high risk of serotonin syndrome (1)

  • is limited experience with this switch so extra caution is required to avoid serotonin syndrome (1)

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.